WO2011056486A3 - Dispositifs, méthodes et composition permettant de lutter contre les infections - Google Patents

Dispositifs, méthodes et composition permettant de lutter contre les infections Download PDF

Info

Publication number
WO2011056486A3
WO2011056486A3 PCT/US2010/053884 US2010053884W WO2011056486A3 WO 2011056486 A3 WO2011056486 A3 WO 2011056486A3 US 2010053884 W US2010053884 W US 2010053884W WO 2011056486 A3 WO2011056486 A3 WO 2011056486A3
Authority
WO
WIPO (PCT)
Prior art keywords
devices
methods
composition
controlling infections
infections
Prior art date
Application number
PCT/US2010/053884
Other languages
English (en)
Other versions
WO2011056486A2 (fr
Inventor
Paul J. Rucinski
Original Assignee
Innovation Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Technologies, Inc. filed Critical Innovation Technologies, Inc.
Priority to CN201080048369XA priority Critical patent/CN102711709A/zh
Priority to EP10828816.8A priority patent/EP2493442A4/fr
Priority to JP2012536912A priority patent/JP2013508457A/ja
Priority to CA2778081A priority patent/CA2778081A1/fr
Publication of WO2011056486A2 publication Critical patent/WO2011056486A2/fr
Publication of WO2011056486A3 publication Critical patent/WO2011056486A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne des méthodes et des dispositifs inédits, extrêmement efficaces et pratiques d'irrigation des plaies.
PCT/US2010/053884 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections WO2011056486A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201080048369XA CN102711709A (zh) 2009-10-26 2010-10-24 用于控制感染的装置、方法和组合物
EP10828816.8A EP2493442A4 (fr) 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections
JP2012536912A JP2013508457A (ja) 2009-10-26 2010-10-24 感染を制御するための装置、方法、および組成物
CA2778081A CA2778081A1 (fr) 2009-10-26 2010-10-24 Dispositifs, methodes et composition permettant de lutter contre les infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25490609P 2009-10-26 2009-10-26
US61/254,906 2009-10-26

Publications (2)

Publication Number Publication Date
WO2011056486A2 WO2011056486A2 (fr) 2011-05-12
WO2011056486A3 true WO2011056486A3 (fr) 2011-09-29

Family

ID=43970646

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/053884 WO2011056486A2 (fr) 2009-10-26 2010-10-24 Dispositifs, méthodes et composition permettant de lutter contre les infections

Country Status (5)

Country Link
EP (1) EP2493442A4 (fr)
JP (1) JP2013508457A (fr)
CN (1) CN102711709A (fr)
CA (1) CA2778081A1 (fr)
WO (1) WO2011056486A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5872430B2 (ja) * 2012-09-20 2016-03-01 日本電子照射サービス株式会社 グルコン酸クロルヘキシジン製剤、消毒用キット及び滅菌方法
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
AU2014361828A1 (en) * 2013-12-12 2016-06-30 Innovation Technologies, Inc. Materials and methods for controlling infections
EP3177333A4 (fr) * 2014-08-08 2018-04-04 Innovation Technologies, Inc. Matériaux et procédés pour lutter contre les infections avec traitement des plaies par pression négative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214866B1 (en) * 1996-08-01 2001-04-10 Smithkline Beecham Pharmaceuticals (Pty) Limited Composition comprising mupirocin and chlorhexidine
US20040185028A1 (en) * 2003-03-19 2004-09-23 Zhenze Hu Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
US20060051385A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Cationic antiseptic compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
DE602004011953T2 (de) * 2003-09-22 2009-03-05 Innovation Technologies, Inc., Gainsville Wundirrigationsvorrichtung und verfahren
US20050124946A1 (en) * 2003-12-05 2005-06-09 Sergio Landau Wound irrigation apparatus and method
WO2005084627A1 (fr) * 2004-03-01 2005-09-15 University Of Iowa Research Foundation Compositions de chlorhexidine sans alcool
JP2006117587A (ja) * 2004-10-22 2006-05-11 Dainippon Sumitomo Pharma Co Ltd 殺菌消毒剤組成物
US20070036846A1 (en) * 2005-08-15 2007-02-15 Tsang Wing W M Wound dressing and method of manufacture thereof
US7540860B2 (en) * 2006-01-23 2009-06-02 Keith Stamler Wound irrigation splashback shield
PL2094331T3 (pl) * 2006-12-19 2017-04-28 Innovation Technologies, Inc. Urządzenia i roztwory do dostarczania środków czynnych do miejsc docelowych

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214866B1 (en) * 1996-08-01 2001-04-10 Smithkline Beecham Pharmaceuticals (Pty) Limited Composition comprising mupirocin and chlorhexidine
US20040185028A1 (en) * 2003-03-19 2004-09-23 Zhenze Hu Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
US20060051385A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Cationic antiseptic compositions and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2493442A4 *

Also Published As

Publication number Publication date
JP2013508457A (ja) 2013-03-07
EP2493442A4 (fr) 2013-05-15
CA2778081A1 (fr) 2011-05-12
EP2493442A2 (fr) 2012-09-05
WO2011056486A2 (fr) 2011-05-12
CN102711709A (zh) 2012-10-03

Similar Documents

Publication Publication Date Title
EP2467173B8 (fr) Pansements, procédés d'utilisation de ceux-ci et procédés de formation de ceux-ci
WO2011142858A3 (fr) Variants de la chlorotoxine, conjugués, et leurs méthodes d'utilisation
WO2012006538A8 (fr) N-éthyl-n-phényl-1,2-dihydro-4-hydroxy-5-chloro-1-méthyl-2-oxoquinoléine-3-carboxamide deutéré, sels de ce composé et utilisations correspondantes
EP2629975A4 (fr) Dispositifs, systèmes et procédés pour la fabrication de tissu
WO2011072099A3 (fr) Compositions et procédés comprenant des variants de protéase
GB2470040A8 (en) Wound dressing materials.
EP2387849A4 (fr) Alignement de contour basé sur une trame pour guidage et application chimique à vitesse variable
EP2499195A4 (fr) Laveurs d'oxygène, compositions comprenant les laveurs, et articles réalisés à partir des compositions
WO2011130222A3 (fr) Compositions et procédés comprenant des protéases variantes
WO2009130479A3 (fr) Virus
EP2527404A4 (fr) Composition pour élément résorbable aux rayons ultraviolets, et élément résorbable aux rayons ultraviolets comprenant celle-ci
WO2011133504A3 (fr) Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes
WO2011075636A3 (fr) Épitopes et agents de liaison destinés à wise
EP3648603A4 (fr) Compositions antimicrobiennes, désinfectantes et cicatrisantes et leurs procédés de production et d'utilisation
TWI563029B (en) Melt-spun fiber, film or hose and method for making the same, and uses thereof
WO2012112548A3 (fr) Firmocidine, une molécule antimicrobienne produite par staphylococcus epidermidis
WO2012017321A3 (fr) Traitement de la dyslipidémie
WO2009152167A3 (fr) Administration d'agents thérapeutiques
WO2010005622A3 (fr) Dispositifs télescopiques
WO2013052683A3 (fr) Nanomousse métallique antibactérienne et procédés associés
WO2012037570A3 (fr) Table à rallonge
WO2011117271A3 (fr) Mélanges fongicides basés sur des azolopyrimidinylamines
WO2011056486A3 (fr) Dispositifs, méthodes et composition permettant de lutter contre les infections
WO2011050188A8 (fr) Anticorps anti-hepsine et procédés d'utilisation de ceux-ci
WO2011014288A3 (fr) Articles ayant un faible coefficient de frottement, procédés de fabrication associés et procédés d'utilisation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080048369.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10828816

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2778081

Country of ref document: CA

REEP Request for entry into the european phase

Ref document number: 2010828816

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010828816

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012536912

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE